Pure Global
NCT06261385

Development of Typology-based Smoking Relapse Prevention: A Q-methodology and a Pilot Randomized Controlled Trial

The University of Hong Kong·ClinicalTrials.gov·behavioralRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Smoking Cessation
Drug/Device/Intervention
typology-based intervention
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
The University of Hong Kong
Location
Hong Kong, China
Timeline & enrollment
Phase
N/A
Start date
Jan 23, 2024
End date
Jan 31, 2025
Enrollment
510 participants
Primary outcome

self-reported abstinence in the past 30 days at 2-month follow-up,iScreen OFD Cotinine Saliva Test Kit (30ng/ml) biochemical validated tobacco abstinence,the difference of the feasibility and acceptability score of the typology-based intervention between the intervention and control group.

Summary

This study aims to develop a typology-based intervention delivered by smoking cessation (SC)
 counselors to prevent smoking relapse in ex-smokers who recently quit. The two main research
 questions include (1) Can a typology-based smoking relapse prevention intervention be
 feasible and accepted by the smokers and SC counselors who deliver the new intervention? (2)
 What is the preliminary evidence on the efficacy of the typology-based smoking relapse
 prevention to increase tobacco abstinence in ex-smokers who have recently quit? If the
 intervention shows at least a small effect size (i.e. risk ratio1.3), or the intervention is
 feasible while modifications can potentially increase the efficacy, a future definitive RCT
 is warranted.

ICD-10 classifications
Mental and behavioural disorders due to use of tobacco withdrawal stateTobacco useExposure to tobacco smokeToxic effect: Tobacco and nicotineMental and behavioural disorders due to use of tobacco
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06261385
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06261385 through Pure Global AI's free database. This phase not specified trial is sponsored by The University of Hong Kong and is currently Recruiting. The study focuses on Smoking Cessation. Target enrollment is 510 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.